Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
09/2013
09/25/2013CN103315974A Osmotic pump type controlled release preparation containing donepezil and its salt and preparation method thereof
09/25/2013CN103315973A Quetiapine osmotic pump controlled release preparation
09/25/2013CN103315948A Nimodipine polymer blending micelle preparation and preparation method thereof
09/25/2013CN103315584A Drug pillow for regulating blood pressure and inducing sleep
09/25/2013CN103315583A Medical pillow with insomnia prevention and treatment function
09/25/2013CN102813831B Preparation method for traditional Chinese medicine for treating fire excess from yin deficiency type insomnia
09/25/2013CN102793834B Traditional Chinese medicine for treatment of depression
09/25/2013CN102764257B Flupirtine maleate sustained release tablet
09/25/2013CN102727657B Medicament for treating neurasthenia
09/25/2013CN102716084B Fluoxetine hydrochloride liposome solid preparation
09/25/2013CN102641418B Medicament for treating migraine
09/25/2013CN102580000B Medicament for curing cancer pain and preparation method thereof
09/25/2013CN102579989B Flunarizine hydrochloride and preparation process thereof
09/25/2013CN102579720B Medicament for treating facial paralysis and preparation method thereof
09/25/2013CN102579691B Medicinal oil for acupuncture and preparation method thereof
09/25/2013CN102552827B Medicine for treating epilepsy
09/25/2013CN102526592B Chinese medicinal composition for preventing and treating cardiovascular and cerebrovascular diseases and immune dysfunction
09/25/2013CN102416029B Ginseng submicron powder and preparation method and preparation thereof
09/25/2013CN102349873B Pharmaceutical compositions based on idazoxan salt or one of polymorphs thereof
09/25/2013CN102293886B Chinese medicinal composition for treating insomnia
09/25/2013CN102216271B Crystalline form of a 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compound
09/25/2013CN102028664B Citicoline sodium tablets and preparation method thereof
09/25/2013CN101972471B Application of Ulinastatin in preparing drug for curing autoimmune encephalomyelitis and pharmaceutical composition thereof
09/25/2013CN101743227B Novel histidine derivative
09/25/2013CN101696208B Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with a cyclic amino group as CRF antagonists
09/24/2013US8541453 Modulators of ATP-binding cassette transporters
09/24/2013US8541446 (2S,3R)-N-(2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)benzofurn-2-carboxamide, novel salt forms, and methods of use thereof
09/24/2013US8541440 Derivatives of 5-pyridinyl-1-azabicyclo[3.2.1]octane, preparation method thereof and use of same in therapeutics
09/24/2013US8541427 Phenyl-substituted 2-imino-3-methyl pyrrolo pyrimidinone compounds as BACE-1 inhibitors, compositions, and their use
09/24/2013US8541410 Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use and pharmaceutical preparations comprising them
09/24/2013US8541373 BChE albumin fusions for the treatment of cocaine abuse
09/24/2013US8541034 Electrical producing creams
09/24/2013US8540990 Methods for treating osteoarthritis pain by administering a nerve growth factor antagonist and compositions containing the same
09/24/2013CA2745721C Substituted piperidine spiro pyrrolidinone and piperidinones used as h3 modulators
09/24/2013CA2728451C Salicylamide derivatives as nicotinic alpha 7 modulators
09/24/2013CA2708323C 4-hydroxy-4-methyl-piperidine-1-carboxylic acid (4-methoxy-7-morpholin-4-yl-benzothiazol-2-yl)-amide for the treatment of post-traumatic stress disorder
09/24/2013CA2667210C 1,5-diphenyl-3-pyridinylmethylamino-1,5-dihydropyrrolidin-2-one as a cb-1 receptor modulator
09/24/2013CA2611609C Ampa receptor potentiators
09/24/2013CA2608184C N,n-substituted 3-aminopyrrolidine compounds useful as monoamines reuptake inhibitors
09/24/2013CA2592345C Piperidine and azetidine derivatives as glyt1 inhibitors
09/24/2013CA2490100C Pharmaceutical formulation for use in treating drug withdrawal and preparation method
09/24/2013CA2488394C Sulfur-containing proanthocyanidin oligomer composition and production method thereof
09/24/2013CA2466697C Pharmaceutical compositions containing 3,4-propinoperhydropurines and uses thereof for blocking neuronal transmission
09/24/2013CA2405557C Albumin fusion proteins
09/19/2013WO2013138687A1 Positive allosteric modulators of mglur2
09/19/2013WO2013138602A1 An iloperidone metabolite for use in the treatment of psychiatric disorders
09/19/2013WO2013138463A1 Neurofibromatoses therapeutic agents and screening for same
09/19/2013WO2013138456A1 Lim kinasemodulating agents for neurofibromatoses therapy and methods for screening for same
09/19/2013WO2013138322A1 Esketamine for the treatment of treatment-refractory or treatment-resistant depression
09/19/2013WO2013137778A1 Solid dosage form having neuroprotector, antiamnesic, antioxidant, antihypoxic, and antiischaemic activity (alternatives)
09/19/2013WO2013137777A1 Pharmaceutical composition having neuroprotector, antiamnesic, antioxidant, antihypoxic, neurometabolic and antiischaemic activity (alternatives)
09/19/2013WO2013137479A1 Decahydroquinoxaline derivatives and analogs thereof
09/19/2013WO2013137371A1 Novel pyrimidine compound and medicine comprising same
09/19/2013WO2013136338A1 Modified kisspeptin peptides and uses thereof
09/19/2013WO2013135596A1 Rho kinase inhibitors for use in treating amyotrophic lateral sclerosis
09/19/2013WO2012107706A8 Phenothiazine diaminium salts and their use
09/19/2013US20130245575 Body product and method of delivery
09/19/2013US20130245128 Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes, and parkinson's disease
09/19/2013US20130245045 Selective phosphodiesterase 9a inhibitors as medicaments for improving cognitive processes
09/19/2013US20130245043 Substituted imidazopyrimidin-5(6h)-ones as allosteric modulators of mglur5 receptors
09/19/2013US20130245037 Stabilization of Hypoxia Inducible Factor (HIF) Alpha
09/19/2013US20130245034 Inhibitors Of Histone Deacetylase
09/19/2013US20130244960 Treatment for Alzheimer's Disease
09/19/2013US20130244927 Polynucleotides encoding signal peptide-containing molecules
09/19/2013US20130243780 Antibody Selective for a Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Receptor and Uses Thereof
09/19/2013US20130243768 Multimeric proteins and methods of making and using same
09/19/2013US20130243755 Novel human ulip/crmp protein and use thereof in diagnosis and treatment of cancers and paraneoplastic neurological syndromes
09/18/2013EP2638906A1 Stabilized adhesive preparation containing donepezil
09/18/2013EP2638070A1 Methods and compositions for neural disease immunotherapy
09/18/2013EP2638038A1 Method of treatment for mental disorders
09/18/2013EP2638035A1 Triazole derivatives as ligands for gaba receptors
09/18/2013EP2638031A1 Pyrazole aminopyrimidine derivatives as lrrk2 modulators
09/18/2013EP2638029A1 Triazole derivatives and their use for neurological disorders
09/18/2013EP2638009A2 Fluorinated hdac inhibitors and uses thereof
09/18/2013EP2638008A1 Lactam derivatives useful as orexin receptor antagonists
09/18/2013EP2638005A2 S-t-butyl protected cysteine di-peptide analogs and related compounds
09/18/2013EP2637662A1 Dosing regimen for sedation with cns 7056 (remimazolam)
09/18/2013EP2637658A1 Compositions and methods relating to heat shock transcription factor activating compounds and targets thereof
09/18/2013EP2637657A1 Composition comprising a serotonin receptor agonist and a diketopiperazine for treating migraines
09/18/2013EP2637649A2 Compounds and methods for treating pain
09/18/2013CN1697655B Methods and compositions using immunomodulatory compounds for treatment and management of cancers and other diseases
09/18/2013CN1694959B Non-sequence complementary antiviral oligonucleotides
09/18/2013CN1630665B Anti-A beta antibodies and their use
09/18/2013CN1578779B Small organic molecule regulators of cell proliferation
09/18/2013CN103313988A Imidazotriazinone compounds
09/18/2013CN103313978A Pyrazole aminopyrimidine derivatives as LRRK2 modulators
09/18/2013CN103313705A Percutaneous absorption preparation containing rivastigmine
09/18/2013CN103305458A Method for inducing cholinergic neurons from pluripotent stem cells
09/18/2013CN103304630A GPCR active polypeptide in scorpion venom of Buthus martensii Karsch, and extracting separation and application thereof
09/18/2013CN103304570A Naloxone hydrochloride compound as well as preparation method and pharmaceutical composition of naloxone hydrochloride compound
09/18/2013CN103304564A Beta-carboline derivative containing hydroximic acid as well as preparation method and medical application thereof
09/18/2013CN103304522A Compound with neuroinflammation inhibition activity, as well as preparation method and application thereof
09/18/2013CN103304483A N-3-arylamine-5-cyclopropane spirohydantoin and preparation method and application thereof
09/18/2013CN103301760A Dissolving method of L-tetrahydropalmatine, L-tetrahydropalmatine solution and application of L-tetrahydropalmatine solution
09/18/2013CN103301475A Natural antisense and non-coding rna transcripts as drug targets
09/18/2013CN103301464A 药物组合物 The pharmaceutical composition of
09/18/2013CN103301461A Long-acting injectable preparation, preparation method and application thereof
09/18/2013CN103301432A Drug for treating lamb crazy
09/18/2013CN103301426A Capsule for invigorating circulation and benefiting heart
09/18/2013CN103301421A Chinese medicine composition for treating sciatica